Physician-pharmacist collaboration: A millennial paradigm to reduce medication errors

Journal of the American Osteopathic Association

Volumn 102, Issue 12, 2002, Pages 678-681

  Sweeney, Marc A ^a  

^a Ohio N Univ Raabe Coll of Pharm   (United States)

Author keywords

Adverse drug events; Medication errors; Pharmacist; Physician

Indexed keywords

ARTICLE; COMPETENCE; DRUG FATALITY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; MALPRACTICE; MEDICAL AUDIT; MEDICAL SOCIETY; NEGLIGENCE; PHARMACIST; SAFETY;

COOPERATIVE BEHAVIOR; HUMANS; INTERPROFESSIONAL RELATIONS; MEDICATION ERRORS; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PHYSICIAN'S ROLE;

EID: 0036917265     PISSN: 00986151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kohn LT, Corrigan JM, Donaldson MS, eds. To Err is Human: Building a Safer Health System. Washington, DC: National Academy Press, 2000.
2. Johnson N. The use of technology to improve drug therapy outcomes. Formulary. 2000;35:65-70.
3. Griffin JF. More physician-pharmacist cooperation needed [letter]. N Engl J Med. 1986;315(17):1097.
4. Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282(3):267-270.
5. Ritchey FJ, Raney MR. Medical role-task boundary maintenance: Physiclans' opinions on clinical pharmacy. Med Care. 1981;19:90-103.
6. Bradshaw SJ, Doucette WR. Community pharmacists as patient advocates: Physician attitudes. J Am Pharm Assoc. 1998;38:598-602.
7. Fero LA, Marcrom RE, Garrelts L, Bennett MS, Boyd EE, Eddinger L, et al. Collaborative practice agreements between pharmacists and physicians. J Am Pharm Assoc. 1998;38:655-664.
8. Raehl CL, Bond CA, Pitterle M. Pharmaceutical services in U.S. hospitals in 1989. Am J Hosp Pharm. 1992;49:323-346.
9. Raehl CL, Bond CA, Pitterle M. 1992 National clinical pharmacy services survey. Pharmacotherapy. 1994;14(3):282-304.
10. Raehl CL, Bond CA, Pitterle M. 1995 National clinical pharmacy services survey. Pharmacotherapy. 1998;18(2):302-326.
11. Raehl CL, Bond CA. 1998 National clinical pharmacy services study. Pharmacotherapy. 2000;20(4):436-460.
12. Biles JA. The doctor of pharmacy. JAMA. 1983;249:1157-1160.
13. Carter BL. Pharmacotherapy and the primary care physician. Prim Care. 1990;17:469-477.
14. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. JAMA. 1995;274:29-34.
15. Brennan TA, Leape LL, Laird NM, Hebert L, Localio AR Lawthers AG, et al. Incidence of adverse events and negligence in hospitalized patients: Results of the Harvard Medical Practice Study I. N Engl J Med. 1991;324:370-376.
16. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients: Excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277:301-306.
17. Johnson JA, Bootman JL. Drug-related morbidity and mortality. Arch Intern Med. 1995;155:1949-1956.
18. Bates DW, Spell, N, Cullen DJ, Burdick E, Laird N, Petersen LA, et al. The costs of adverse drug events in hospitalized patients. JAMA. 1997;277:307-311.
19. Rosenthal GE, Harper DL, Quinn LM, Cooper GS. Severity-adjusted mortality and length of stay in teaching and nonteaching hospitals. JAMA. 1997;277:485-490.
20. Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA. 1997;277:312-317.
21. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: Results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med. 1999;159(16): 1939-1945.
22. Rainville EC. Impact of pharmacist interventions on hospital readmissions for heart failure. Am J Health Syst Pharm. 1999;56:1339-1340.
23. McMullin ST, Hennenfent JA, Ritchie DJ, Huey WY, Lonergan TP, Schaiff RA, et al. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med. 1999;159:2306-2309.
24. Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy. 1999;19:556-564.
25. Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacy staffing, and the total cost of care in United States hospitals. Pharmacotherapy. 2000;20:609-621.
26. Jones RA, Lopez LM, Beall DG. Cost-effective implementation of clinical pharmacy services in an ambulatory care clinic. Hosp Pharm. 1991;26:778-782.
27. Harrison DL, Bootman JL, Cox ER. Cost-effectiveness of consultant pharmacists in managing drug-related morbidity and mortality at nursing facilities. Am J Health Syst Pharm. 1998;55:1588-1594.
28. Knoell DL, Jerome JF, Marsh CB, Allen JN, Pathak DS. Measurement of outcomes in adults receiving pharmaceutical care in a comprehensive asthma outpatient clinic. Pharmacotherapy. 1998;18:1365-1374.
29. Furmaga EM. Pharmacist management of a hyperlipidemia clinic. Am J Hosp Pharm. 1993;50:91-95.
30. Lilley SH, Cummings DM, Whitley CW, Pippin HJ. Integration of a pharmacotherapy clinic in a university-based family practice center. Hosp Pharm. 1998;33:1105-1110.